Two further themes were identified using inductive methods: mental clarity and feeling understood. The effect of mental clarity or feeling understood is not captured by any of the domains in EQ-5D-5l or SF6D. The ICECAP-A is potentially able to capture the impact of these themes in the respective domains ability to achieve and progress and ability to gain support. Conclusions: This study suggests that three existing measures (EQ5D, SF6D, and ICECAP-A) were successful, in different degrees, to capture the impact of presenteeism that result from the aspects and symptoms of IA. Potentially, these measures may be used in economic evaluations to capture the impact of presenteeism. Background: Physical activity levels are low in people >65 years and those with chronic musculoskeletal pain, yet increased physical activity can lead to reduced pain. Walking is acceptable to older people with pain, but interventions to increase walking in this population are untested. The iPOPP pilot trial investigated feasibility and acceptability of a walking intervention delivered by trained Health Care Assistants (HCAs) in 4 general practices in an individually randomised three arm trial (usual primary care, pedometer only and iPOPP, n=50 each arm). The iPOPP intervention comprised two consultations (1 week apart) and 8 weekly follow-up prompts (postcard, email or text). Objectives: To investigate fidelity of the iPOPP intervention to inform design of a full-scale randomised controlled trial. Methods: HCAs were asked to record 6 consultations (3 participants, first and second consultation). A fidelity checklist was developed (aligned to HCA training) and included activities expected (pedometer, user guide, walking diary, pain toolkit given; discussion of walking behaviour and barriers; action planning to develop walking goals; review of progress; positive feedback; revision of goals; relapse prevention strategies; and, preference for weekly prompts). Activities were scored as "Yes" (completed as intended), "partial" (some evidence), "No" (no evidence) or "NA" (not applicable). The checklist was applied to one recording (JP, CCG, CJ). Minor amendments clarified interpretation of checklist headings before application to 3 more recordings (JP, CCG). JP then scored remaining recordings (n=14). Results: 3 HCAs recorded 18 consultations (9 first, 9 second). Most first consultations did not use the allocated 30 minutes (average 14 minutes). The pedometer, user guide, walking diary and pain toolkit were all given but there was a lack of explanation of the pain toolkit. Evidence of the benefits of walking on pain was well delivered (N=8), motivators to walk and goals were discussed in all 9, with goals set in 7. Barriers to walking were not always discussed (N=4) exploration of maintenance strategies lacking, especially with those patients who perceived themselves as already physically active. All HCAs arranged a second consultation within one week which were brief (average 6.5 minutes) and focused mainly on use of the pedometer. Patient goals were partially re-visited (N=7) and barriers to walking partially addressed (N=5). Maintenance strategies were not discussed (N=8). Conclusions: Core iPOPP intervention components were well delivered. However we have identified areas to optimise ahead of a full-scale trial (how to discuss barriers to walking and maintenance strategies, development of motivational interviewing skills to support revision of goals, HCA knowledge of local activities). These findings will be triangulated with data from interviews with HCAs and participants to provide further evidence of the feasibility and acceptability of the iPOPP intervention. Objectives: Health services addressing employment needs for people with arthritis are lacking. To address this need, we developed the Making it Work (MiW) program, an online self-management program aimed at helping people with inflammatory arthritis (IA) deal with employment issues. As part of a randomized controlled trial evaluating program effectiveness, this study reports on participants' experiences with various aspects of the program. Methods: All participants in the MiW program between Jan20 and Dec7 2016 were included. Participants were recruited from rheumatologist practices, outpatient arthritis programs, a national consumer organization (Arthritis Consumer Experts), and community advertisements in BC, Alberta and Ontario. Eligibility criteria included: having IA; being currently employed; age 18-59 yrs; concern about their ability to work; and access to a computer. The program consisted of 5 online self-learning modules, 5 online group meetings facilitated by a vocational counsellor, an individual ergonomic assessment by an occupational therapist and an online session with a vocational counsellor. Feedback questionnaires were administered online after participants completed the program. Descriptive analyses were performed. Results: The sample included 69 participants [80% female; mean (SD) age: 45.3 (10.5) yrs; 83% Caucasian; 91% with post-secondary education; 52% with RA, AS: 19%, SLE: 17%; PsA: 12%]. Overall, participants expressed satisfaction with the program with 94.2% agreeing (69.6% strongly and 24.6% somewhat) they would recommend this program to someone they know. When asked to rate program components on a scale of 0-10 where 0=not useful at all and 10=very useful, participants rated all components favourably: median [25Q;75Q] for online modules: 8 [7;10], with highest ratings for the fatigue module (rated 10 by 42%); online group meetings: 9 [7.5;10]; ergonomic and VRC assessments: 8 [7;10] each. Although participants had 2 weeks between meetings to complete the module, 55% did the module the week of, and 42% the day before, the group meeting. Median time to complete each module was 60 min. 81% enjoyed being able to listen to the information (somewhat or strongly agreed), although 35% stated they would have preferred to read the information than listen to a narrator. 74% expect to use the online modules again in the future. Participants were also satisfied with the online group meetings: 93% were very or somewhat satisfied with the group facilitation; 87% satisfied with the group dynamic; 84% comfortable with the online format. When asked to rate their online group meeting experience on a scale of 1 to 10, median [25Q;75Q] ratings for: ability to follow group discussion was 10 [9;10]; getting to know other participants: 7 [7;10]; feeling listened to and understood 9 [8;10]; feeling that group was supportive 9 [7;10]. 20% said it was difficult for them to attend group meetings. Conclusions: In general, participants were highly satisfied with all aspects of the MiW program. Our study demonstrates that self-management programs, including group meetings, can be successfully delivered using an online format, which facilitates wider dissemination, with greater convenience to patients, and at lower costs. Background: Adherence to medication depends on several factors such as medication beliefs, psychosocial factors, illness beliefs and concerns. The consequences of non-adherence are not insignificant, both from the clinical and health economic aspects. Objectives: To assess medication adherence of patients taking biologics who are in remission or who have low disease activity and patients' perception of disease progression. Methods: Forty-four consecutive patients attending a dedicated biologic clinic and treated with TNF inhibitors were interviewed following their visit. Patients were asked about adherence to treatment, adverse effects, concerns about biologics and their perception of disease progression. Demographic and disease activity data were recorded. Results: Forty-four patients (23 females, 21 males) participated in the survey (21 suffered from rheumatoid arthritis, 17 from ankylosing spondylitis and 6 from psoriatic arthritis). The mean age was 55.1 (SD 12.62) years. The mean DAS28 was 2.26 (SD 1.03) and the mean BASDAI was 4.21 (SD 2.1). Minimal or no pain was reported by 75%, mild or no fatigue by 78% and 77% had no restriction of activities of daily living. Medication adherence was reported as high by 68% and moderate by 32%. There were no patients who had a low level of adherence. 5% of patients admitted to be unaware of the need to omit their biologic when ill and 40% when requiring surgery. One out of 4 patients reported to have experienced adverse events, most commonly infections. 19% claimed to be moderately or very concerned about the adverse effects. On further questioning about the severity of potential adverse effects, 45% were unsure as to what the severity might be. When asked about duration of therapy, 29% replied more than 10 years; whilst 71% were unsure on when, if ever, the biologic is going to be stopped. Patients were also asked whether they believed that the biologic had successfully stopped further joint damage and 68% replied yes, 9% replied no, whilst 23% were unsure. Of those who replied yes, this perception was based on the absence or reduction of symptoms. Conclusions: In this cohort of patients with low disease activity or remission, a third of patients still reported sub-optimal adherence to TNF inhibitor use. The benefits of adherence to biologic therapies need to be reinforced at every visit and factors leading to non-adherence addressed. Adverse effects remain a major concern that needs to be addressed, even in patients who have been on biologics for many years and have sustained remission or low disease activity. A quarter of patients were unsure whether biologics have stopped joint damage. Patients' perception of joint damage progression needs to be explored to find ways of making it more understandable to patients. Objectives: To know the sources by which patients with rheumatic diseases treated with subcutaneous (SC) biological drugs obtain information on their treatment, their satisfaction with the information received from the hospital staff and their perception of the degree of information they have. Methods: RHEU-LIFE was a survey handed by 50 rheumatologists from Spanish outpatients hospital offices to patients on SC biological drugs. They completed the survey anonymously at home and returned it by pre-paid post-mail. They selected from a list their sources of information (being able to mark all their sources), their satisfaction with the information received from the hospital staff and whether they had sought additional information in other sources. Results: The survey was handed to 1000 patients and 592 returned it (59.2%, mean age 51.7 years, 57.6% women). The source of information most frequently mentioned was the rheumatologist (table) and, infrequently, the nurse or the hospital pharmacist. 46.1% had received information on the SC biological only orally, 6.0% written and 45.2% in both ways. The percentages quite or very satisfied with the information received were 42.6% and 44.5% respectively, 10.6% felt "neither satisfied nor dissatisfied" and 2.1% and 0.2% dissatisfied or very dissatisfied. The % quite/very satisfied was higher when the information came from the rheumatologist (89.6% vs 59.6% when the rheumatologist was not mentioned as source of information, p<0.001), and also when information was given both oral and written (92.8% vs 86.1% if only oral information was given, p=0.0125). Some 45.2% had sought information on the SC biological in sources different to the hospital staff, the % being higher among younger patients (<43 years: 65.2%: 43-52 years: 51.4%, 53-61 years: 39.1%, >61 years: 20.6%, p<0.001) those with higher education level (without studies: 14.3%, primary: 31.6%, secondary: 55.6%, vocational: 59.5%, university or higher degrees: 64.9%, p<0.001), and in those treated with a first biological SC drug (49.9%, vs. 37.7% and 37.2% with a second or third or further, p=0.014).
Sources from which patients received information on the different treatments and on the biological drug (patients could mark more than one option)
General information
Information on the SC biological Conclusions: Patients with rheumatic diseases mention the rheumatologist as their main source of information. The % who mentioned nurses or pharmacists was low, although the latter are very frequently visited for dispensing the drug. Satisfaction with the information received was high, but clearly lower when the rheumatologist did not inform the patient. Nearly half reported having sought information in sources other than the hospital staff.
